title: Pediatric renal transplantation: comparative study with renal transplantation in the adult population.
abstract: OBJECTIVE
  To retrospectively review our experience with pediatric renal transplantation and to compare the results with the adult population.
  
  
  METHODS
  Between January 1981 and August 2003, 74 renal transplants were performed in patients < or =18 years at the time of the transplant--the pediatric group versus 1153 patients in the adult group. We analyzed various risk factors for actuarial kidney graft and patient survivals using the Kaplan-Meier method.
  
  
  RESULTS
  Median ages were 13.8 +/- 3.5 and 42.6 +/- 2.4 years, respectively. There was no statistically significant difference in the human leukocyte antigen matching or immunosuppression. There was, however, a younger donor age and shorter ischemia time in the pediatric group. Overall, kidney transplant survival rates for patients < or =18 years at 1, 2, 5, and 10 years were 94.4%, 91.3%, 70.6%, and 58.2%, respectively, with no significant difference for patients older than 18 (91.2%, 89.3%, 78.8%, 60.5%, P = .4325). There was a significantly decreased graft survival in the adult group at 10 years when the donor age was over 60 years and when the ischemia time was > or =20 hours. The incidence of delayed graft function and the creatinine levels of functioning grafts did not differ between the two groups. During the follow-up, acute rejections were more frequent in the younger group. Patient survival in the pediatric group at 1, 2, 5, and 10 years was 98.6%, 98.8%, 98.6%, and 90.3%, respectively, significantly lower in the adult group (95.3%, 94.0%, 87.9%, 76.8%, P < .02).
  
  
  CONCLUSIONS
  Renal transplantation may be successfully performed in the pediatric patients with end-stage renal disease. Overall graft survival at 10 years did not differ significantly between the two groups. There is a higher incidence of acute rejections but longer patient survival in the pediatric population.
authors.affiliation: Department of Urology and Renal Transplantation, University Hospital of Coimbra, Coimbra, Portugal. parada.belmiro@netc.pt
authors.forename: B
authors.initials: B
authors.lastname: Parada
authors.forename: A
authors.initials: A
authors.lastname: Figueiredo
authors.forename: P
authors.initials: P
authors.lastname: Nunes
authors.forename: C
authors.initials: C
authors.lastname: Bastos
authors.forename: F
authors.initials: F
authors.lastname: Macário
authors.forename: A
authors.initials: A
authors.lastname: Roseiro
authors.forename: V
authors.initials: V
authors.lastname: Dias
authors.forename: F
authors.initials: F
authors.lastname: Rolo
authors.forename: A
authors.initials: A
authors.lastname: Mota
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology; D006650:Histocompatibility Testing; D006801:Humans; D007676:Kidney Failure, Chronic / Q000145:classification / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome